A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal Cancer

NCT07573397 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
88
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Fudan University